Cargando…
Future perspectives of uveal melanoma blood based biomarkers
Uveal melanoma (UM) is the most common primary intraocular malignancy affecting adults. Despite successful local treatment of the primary tumour, metastatic disease develops in up to 50% of patients. Metastatic UM carries a particularly poor prognosis, with no effective therapeutic option available...
Autores principales: | Beasley, Aaron B., Chen, Fred K., Isaacs, Timothy W., Gray, Elin S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130512/ https://www.ncbi.nlm.nih.gov/pubmed/35190695 http://dx.doi.org/10.1038/s41416-022-01723-8 |
Ejemplares similares
-
Incidence and mortality of uveal melanoma in Australia (1982–2014)
por: Beasley, Aaron B, et al.
Publicado: (2023) -
Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma
por: Beasley, Aaron, et al.
Publicado: (2018) -
Blood Biomarkers of Uveal Melanoma: Current Perspectives
por: Bande Rodríguez, Manuel F, et al.
Publicado: (2020) -
Detection of metastases using circulating tumour DNA in uveal melanoma
por: Beasley, Aaron B., et al.
Publicado: (2023) -
Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture
por: Beasley, Aaron B., et al.
Publicado: (2021)